مقايسه تزريق داخل ضايعه گلوكانتيم به تنهايي و توأماً با كرايوتراپي در درمان ليشمانيوز جلدي روستايي:كارآزمايي باليني تصادفي

Hotez PJ, Savioli L, Fenwick A. Neglected Tropical Diseases of the Middle East and North Africa:Review of Their Prevalence, Distribution, and Opportunities for Control. J Plos Neg Trop Dis 2010;6(2):1-8.

WHO. Working to overcome the global impact of neglected diseases. First WHO report on neglected tropical diseases. 2010;Geneva, Switzerland.

WHO. TDR Strategic Direction for Research:Leishmaniasis. Available at:www.who.int/tdr 2002;Geneva, Switzerland.

Islamic Republic of Iran Ministry of Heath &Medical Education. [Principles of disease prevention and surveillance]. Tehran:Center for disease control 2008:249-255.[Persian].

Zijstra EE, Siddig Ali M, El-Hassan AM. Kala-azar in diplaced people from Southern Sudan:epidemiological, clinical and therapeutic findings, Trans. R. Soc. Trop. Med. Hyg,85(1991) 365-369.

Ministry of Health and Medical Education (I.R.Iran) center for Disease Management. Principles of leishmaniasis prevention & surveillance. Tehran:2007:32-36.[Persian].

Herbert MG. Protozoal Diseases. London:Oxford University Press;1999:1-281.

Morsy TA, Abdel Rahman EG, Ahmed MM. Treatment of cutaneous leishmaniasis with Pentostam or cryosurgery. J Egypt Soc Parasitol. 1989;19(2):533-43.

Teixeira AC, Paes MG, Guerra Jde O, Prata A, Silva-Vergara ML. Low efficacy of azithromycin to treat cutaneous leishmaniasis in Manaus, AM, Brazil. Rev Inst Med Trop Sao Paulo 2007;49(4):235-238.

Alavi S.M, AlaviL. Efficacy of azithromycin in the treatment of cutaneous leishmaniasis. J Gorgan Uni Med Sci 2008;10(4):1-5. [Persian].

Mostaghim M, Heiazi SH, Tolouei S, Asilian A, Sadeghian G, Shatalebi MA, et al. Study of therapeutic effect of Paromomycin Sulfate in combination with Gentamicin Sulfate film for treatment of cutaneous Leishmaniasis. Urmia Medical J 2002;13(2):136-144.[Persian].

Haftbaradaran H, Nilforoushzadeh MA, Jaffary F. The Efficacy of 5% Trichloroacetic Acid Cream in the Treatment of Cutaneous Leishmaniasis Lesions. J Knowlede & Health Uni Med Sci 2010;4(4):18-21.[Persian].

Al-Majali O, Routh HB, Abuloham O, Bhowmik KR, Muhsen M, Hebeheba H. A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis. Int J Dermatol 1997;36(6):460-2.

Bassiouny A, El Meshad M, Talaat M, Kutty K, Metawaa B. Cryosurgery in cutaneous leishmaniasis. Br J Dermatol 1982;107(4):467-74.

Leibovici V, Aram H. Cryotherapy in acute cutaneous leishmaniasis. Int J Dermatol 1986;25(7):473-5.

Alkhawajah AM, Larbi E, Al-Gindan Y, Abahussein A, Jain S. Treatment of cutaneous leishmaniasis with antimony:intramuscular versus intralesional administration. Ann Trop Med Parasitol 1997;91(8):899-905.

Sharquie KE, Al-Talib KK, Chu AC. Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony. Br J Dermatol 1988;119(1):53-7.

Yazdanpanah MJ, Ebrahimirad M, Khazaeinejad S. Comparison between intralesional glucantime injection and cryotherapy in papular cutaneous leishmaniasis. J Gorgan Uni Med Sci. 2006;3(19):16-19.[Persian].

Salmanpour R, Handjani F, Nouhpisheh MK. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate(Glucantime) for the treatment of cutaneous leishmaniasis. J Dermatolog Treat 2001;12(3):159-162.[Persian].

Faghihi G, Tavakoli-kia R. Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate. Clin Exp Dermatol 2003;28(1):6-13.[Persian].

Al-Gindan Y, Kubba R, Omer AH, el-Hassan AM. Cryosurgery in old world cutaneous leishmaniasis. Br J Dermatol 1988;118(6):851-4.

Bassiouny A, El Meshad M, Talaat M, Kutty K, Metawaa B. Cryosurgery in cutaneous leishmaniasis. Br J Dermatol 1982;107(4):467-474.

Gurei MS, Tatli N, Ozbilge H, Erel O, Seyrek A, Kocyigit A, et al. Efficacy of cryotherapy and intralesional pentostam in treatment of cutaneous leishmaniasis. J Egypt Soc Parasitol 2000;30(1):169-76.

Asilian A, Momeni A, Faghihi G, Sadeghi V, Sadeghi M, Sadeghi H. A comparison between cryotherapy alone and combined with intralesional Glucantime injection in the treatment of papulonodular Leishmaniasis. J Dermatol 2002;6(2):30-33. [Persian].

Moskowitz PF, Kurban AK. Treatment of cutaneous leishmaniasis:retrospectives and advances for the 21st century. Clin Dermatol 1999;17(3):305-315.

Rassi Y, Saghafipour A, Abai MR, Oshaghi MA. Phlebotomus papatasi and meriones libycus as the vector and reservoir host of cutaneous leishmaniasis in Qomrood district, Qom province. Central Iran, Asian pacific Journal of Tropical Medicine.4:97-100.